GO
Loading...

Johnson & Johnson

More

  • Final Glance: Medical Devices companies Friday, 24 Oct 2014 | 6:35 PM ET

    Allergan rose$. 84 or. 5 percent, to $184.21. Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Boston Scientific Corp. rose$. 28 or 2.2 percent, to $12.99.

  • Final Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 6:35 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Bristol-Myers Squibb Co. rose $1.13 or 2.2 percent, to $53.63. Hospira rose$. 80 or 1.6 percent, to $52.25.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 64 or. 9 percent, to $69.74. Bristol-Myers Squibb Co. rose $1.00 or 1.9 percent, to $53.50. Hospira rose$. 48 or. 9 percent, to $51.93.

  • Midday Glance: Medical Devices companies Friday, 24 Oct 2014 | 1:17 PM ET

    Allergan rose $2.27 or 1.2 percent, to $185.64. Baxter International Inc. rose$. 64 or. 9 percent, to $69.74. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $13.01.

  • Early Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 67 or 1.0 percent, to $69.77. Bristol-Myers Squibb Co. rose $1.28 or 2.4 percent, to $53.78. Hospira rose$. 36 or. 7 percent, to $51.81.

  • Early Glance: Medical Devices companies Friday, 24 Oct 2014 | 10:40 AM ET

    Allergan rose $1.65 or. 9 percent, to $185.02. Baxter International Inc. rose$. 67 or 1.0 percent, to $69.77. Boston Scientific Corp. rose$. 14 or 1.1 percent, to $12.86.

  • WHO: Millions of Ebola vaccine doses ready in 2015 Friday, 24 Oct 2014 | 8:50 AM ET

    Still, the agency warned it's not clear whether any of these will work against the deadly virus that has already killed at least 4,877 people this year in West Africa. Trials of those two most advanced vaccines— one developed by GlaxoSmithKline in cooperation with the U.S. National Institutes of Health, the other developed by the Canadian Public Health Agency...

  • Final Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.10. Bristol-Myers Squibb Co. rose$. 66 or 1.3 percent, to $52.50. Hospira rose $1.37 or 2.7 percent, to $51.45.

  • Final Glance: Medical Devices companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Allergan rose$. 56 or. 3 percent, to $183.37. Baxter International Inc. rose$. 73 or 1.1 percent, to $69.10. Boston Scientific Corp. rose$. 39 or 3.2 percent, to $12.71.

  • NEW YORK, Oct 23- Johnson& Johnson was found not liable by a Texas jury on Thursday in the first case to go to trial over whether Pinnacle hip implants made by the company's DePuy Orthopaedics unit were defective. The Dallas federal jury ruled unanimously against the plaintiff Kathleen Herlihy-Paoli, who said the two metal-on-metal Pinnacle hips she received...

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $69.09. Bristol-Myers Squibb Co. rose$. 49 or. 9 percent, to $52.33. Hospira rose $1.12 or 2.2 percent, to $51.20.

  • Midday Glance: Medical Devices companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Allergan rose$. 52 or. 3 percent, to $183.33. Baxter International Inc. rose$. 72 or 1.1 percent, to $69.09. Boston Scientific Corp. rose$. 25 or 2.0 percent, to $12.57.

  • Early Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 59 or. 9 percent, to $68.96. Bristol-Myers Squibb Co. rose$. 36 or. 7 percent, to $52.20. Hospira rose$. 74 or 1.5 percent, to $50.82.

  • Early Glance: Medical Devices companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Allergan rose $1.67 or. 9 percent, to $184.48. Baxter International Inc. rose$. 59 or. 9 percent, to $68.96. Medtronic rose$. 54 or. 8 percent, to $65.20.

  • *Topic expected to be discussed at Geneva vaccines meeting. LONDON/ GENEVA, Oct 23- Drugmakers are looking for some kind of indemnity from governments or multilateral agencies against possible losses or claims arising from the widespread emergency use of new Ebola vaccines in Africa. While the issue will not delay the industry's ongoing work to accelerate...

  • *Topic expected to be discussed at Geneva vaccines meeting. LONDON/ GENEVA, Oct 23- Drugmakers are looking for some kind of indemnity from governments or multilateral agencies for the widespread emergency use of new Ebola vaccines in Africa. While the issue will not delay the industry's ongoing work to accelerate production and clinical testing of three...

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.84. Hospira fell$. 80 or 1.6 percent, to $50.08.

  • Final Glance: Medical Devices companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Allergan fell $3.35 or 1.8 percent, to $182.81. Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Boston Scientific Corp. rose$. 29 or 2.4 percent, to $12.32.

  • *European Commission to provide 100 million euros. The move shows how momentum is building to get medical interventions-- and particularly vaccines-- to West Africa as soon as possible to control the world's worst Ebola outbreak, which, according to official figures, has killed nearly 5,000 people, most of them in Liberia, Sierra Leone and Guinea.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $68.41. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.94. Hospira rose$. 09 or. 2 percent, to $50.97.